InvestingPro analysis reveals that Amgen has maintained a robust gross profit margin of 68.71% and generated substantial levered free cash flow of $10.39 billion over the last twelve months.

Want deeper insights into Amgen's financial health? InvestingPro subscribers get access to over 30 additional financial metrics and exclusive analysis, helping investors make more informed decisions.

Want deeper insights into Amgen's financial health and growth potential? InvestingPro offers exclusive analysis and metrics that go beyond surface-level data, with over 8 additional ProTips ...

InvestingPro analysis reveals that Amgen has maintained a robust gross profit margin of 68.71% and generated substantial levered free cash flow of $10.39 billion over the last twelve months. Looking ...

InvestingPro analysis reveals that Amgen has maintained a robust gross profit margin of 68.71% and generated substantial levered free cash flow of $10.39 billion over the last twelve months. Looking ...